Ca2+ channel regulation by transforming growth factor-β1 and bone morphogenetic protein-2 in developing mice myotubes

Journal of Physiology

Volumn 559, Issue 1, 2004, Pages 41-54

  Mejia Luna, Lizbeth ^a   Avila, Guillermo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VOLTAGE GATED CALCIUM CHANNEL; BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CALCIUM CONDUCTANCE; CELL DENSITY; CELL FUSION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; ELECTRIC CAPACITANCE; ELECTRIC POTENTIAL; EXPERIMENTATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NEWBORN; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RECORDING; REGULATORY MECHANISM; CALCIUM CURRENT; CHANNEL GATING; CURRENT DENSITY; WHOLE CELL PATCH CLAMP; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; MUSCLE CELL; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; BONE MORPHOGENETIC PROTEINS; CALCIUM CHANNELS; CELLS, CULTURED; MICE; MUSCLE FIBERS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4444275430     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.066852     Document Type: Article

References (44)

1. 2+ current and charge movements in skeletal myotubes promoted by the beta-subunit of the dihydropyridine receptor in the absence of ryanodine receptor type 1. Biophys J 84, 942-959.
2. 2+ channel. J General Physiol 115, 467-480.
3. 2+ channel expression. J Biol Chem 276, 17732-17738.
4. Bar-Sagi D & Prives J (1983). Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion. J Cell Biol 97, 1375-1380.
5. Beam KG & Franzini-Armstrong C (1997). Functional and structural approaches to the study of excitation-contraction coupling. Meth Cell Biol 52, 283-306.
6. Beam KG & Knudson CM (1988a). Calcium currents in embryonic and neonatal mammalian skeletal muscle. J General Physiol 91, 781-798.
7. Beam KG & Knudson CM (1988b). Effect of postnatal development on calcium currents and slow charge movement in mammalian skeletal muscle. J General Physiol 91, 799-815.
8. + channels. News Physiol Sci 17, 22-26.
9. 1H mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice. J Physiol 539, 681-691.
10. 2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc Natl Acad Sci U S A 97, 7627-7632.
11. + currents in developing skeletal myoblasts are expressed in a sequential program: reversible suppression by transforming growth factor beta-1, an inhibitor of the myogenic pathway. J Neurosc 9, 3443-3453.
12. Chen JC & Goldhamer DJ (2003). Skeletal muscle stem cells. Reprod Biol Endocrinol 1, 101.
13. 2+ channels in mammalian skeletal muscle cells in culture. Proc Natl Acad Sci U S A 83, 517-521.
14. David JD, See WM & Higginbotham CA (1981). Fusion of chick embryo skeletal myoblasts: role of calcium influx preceding membrane union. Dev Biol 82, 297-307.
15. Dirksen RT (2002). Bi-directional coupling between dihydropyridine receptors and ryanodine receptors. Front Biosci 7, d659-670.
16. Dirksen RT & Beam KG (1995). Single calcium channel behavior in native skeletal muscle. J General Physiol 105, 227-247.
17. Florini JR, Ewton DZ & Coolican SA (1996). Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17, 481-517.
18. Florini JR, Roberts AB, Ewton DZ, Falen SL, Flanders KC & Sporn MB (1986). Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem 261, 16509-16513.
19. Gonoi T & Hasegawa S (1988). Post-natal disappearance of transient calcium channels in mouse skeletal muscle: effects of denervation and culture. J Physiol 401, 617-637.
20. Hamill OP, Marty A, Neher E, Sakmann B & Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391, 85-100.
21. Horsley V & Pavlath GK (2004). Forming a multinucleated cell: molecules that regulate myoblast fusion. Cells Tissues Organs 176, 67-78.
22. Katagiri T, Akiyama S, Namiki M, Komaki M, Yamaguchi A, Rosen V et al. (1997). Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Exp Cell Res 230, 342-351.
23. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T et al. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127, 1755-1766.
24. Kawabata M, Imamura T & Miyazono K (1998). Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9, 49-61.
25. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC et al. (1993). Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90, 770-774.
26. Massague J, Cheifetz S, Endo T & Nadal-Ginard B (1986). Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A 83, 8206-8210.
27. Matzuk MM (1995). Functional analysis of mammalian members of the transforming growth factor-β superfamily. Trends Endocrinol Metab 6, 120-127.
28. 2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochim Biophys Acta 1241, 59-116.
29. Nakai J, Dirksen RT, Nguyen HT, Pessah IN, Beam KG & Allen PD (1996). Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 380, 72-75.
30. 2+ channels in mouse skeletal myotubes. J Physiol 529, 647-659.
31. Olson EN, Sternberg E, Hu JS, Spizz G & Wilcox C (1986). Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol 103, 1799-1805.
32. Parker MH, Seale P & Rudnicki MA (2003). Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 4, 497-507.
33. Pavlath GK & Horsley V (2003). Cell fusion in skeletal muscle: Central role of NFATC2 in regulating muscle cell size. Cell Cycle 2, 420-423.
34. Perez-Reyes E (2003). Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83, 117-161.
35. Serra R & Chang C (2003). TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res Part C Embryo Today 69, 333-351.
36. 2+ concentration in nutritional medium. Exp Cell Res 58, 163-167.
37. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold Rj, Yin M et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
38. Strube C, Tourneur Y & Ojeda C (2000). Functional expression of the L-type calcium channel in mice skeletal muscle during prenatal myogenesis. Biophys J 78, 1282-1292.
39. Tanabe T, Beam KG, Powell JA & Numa S (1988). Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature 336, 134-139.
40. Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kangawa K et al. (1987). Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328, 313-318.
41. ten Dijke P, Fu J, Schaap P & Roelen BA (2003). Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85, 34-38.
42. 2+ channel gene expression. J Physiol 516, 331-341.
43. Yamaguchi A, Komori T & Suda T (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21, 393-411.
44. Zhang H & Bradley A (1996). Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122, 2977-2986.